WESPAC Advisors SoCal’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-300
Closed -$7K 159
2019
Q1
$7K Hold
300
﹤0.01% 261
2018
Q4
$5K Hold
300
﹤0.01% 282
2018
Q3
$5K Buy
+300
New +$5.85K ﹤0.01% 264
2018
Q2
Sell
-300
Closed -$6K 140
2018
Q1
$6K Hold
300
﹤0.01% 213
2017
Q4
$9K Hold
300
0.01% 193
2017
Q3
$7K Hold
300
﹤0.01% 209
2017
Q2
$7K Hold
300
﹤0.01% 196
2017
Q1
$6.5K Sell
300
-100
-25% -$2.03K ﹤0.01% 203
2016
Q4
$5.96K Buy
+400
New +$5.77K ﹤0.01% 205

Other funds holding EXEL

WESPAC Advisors SoCal's EXEL Position: Q2 2019 in Review

WESPAC Advisors SoCal sold out of Exelixis (EXEL) in Q2 2019, closing a stake of 300 shares — an estimated $7K sold.

WESPAC Advisors SoCal first reported a position in EXEL in Q4 2016 and held it in 9 quarters. The position peaked at $9K in Q4 2017. 346 funds tracked by Wall St. Rank hold EXEL as of Q2 2019.

  • WESPAC Advisors SoCal reported no remaining Exelixis position as of Q2 2019 after selling out during the quarter.
  • WESPAC Advisors SoCal sold 300 Exelixis shares in Q2 2019, an estimated $7K.
  • WESPAC Advisors SoCal first reported a position in Exelixis in Q4 2016 and held it in 9 quarters.
  • WESPAC Advisors SoCal's Exelixis position peaked at $9K in Q4 2017.
  • 346 funds tracked by Wall St. Rank held Exelixis as of Q2 2019.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2019, filed 30 Jul 2019.